Your browser doesn't support javascript.
loading
ALSUntangled #60: light therapy.
Bedlack, Richard; Barkhaus, Paul; Barnes, Ben; Bereman, Michael; Bertorini, Tulio; Carter, Gregory; Crayle, Jesse; Kihuwa-Mani, Sky; Bowser, Robert; Kittrell, Pamela; McDermott, Christopher; Pattee, Gary; Salmon, Kristiana; Wicks, Paul.
Afiliación
  • Bedlack R; Department of Neurology, Duke University, Durham, NC, USA.
  • Barkhaus P; Department of Neurology, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Barnes B; Department of Neurology, Augusta University Medical Center, Augusta, GA, USA.
  • Bereman M; Department of Chemistry, North Carolina State University, Raleigh, NC, USA.
  • Bertorini T; Department of Neurology, Methodist University Hospital, Memphis, TN, USA.
  • Carter G; Department of Neurology, St Lukes Rehabilitation Hospital, Chesterfield, MO, USA.
  • Crayle J; Department of Neurology, Washington University in St Louis School of Medicine, St Louis, MO, USA.
  • Kihuwa-Mani S; University of North Carolina at Greensboro, Lloyd International Honors College, Greensboro, NC, USA.
  • Bowser R; Department of Neurology, Barrow Neurological Institute, Phoenix, AZ, USA.
  • Kittrell P; Department of Neurology, University of Texas Health Science Center, Houston, TX, USA.
  • McDermott C; Department of Neuroscience, University of Sheffield, Sheffield, UK.
  • Pattee G; Department of Neurology, Nebraska Medicine, Omaha, NE, USA.
  • Salmon K; Department of Neurology, McGill Centre for Research in Neuroscience, Montreal, QC, Canada.
  • Wicks P; Independent Consultant, United Kingdom.
Article en En | MEDLINE | ID: mdl-33683159
ALSUntangled reviews alternative and off-label treatments for people with ALS. Here we review light therapy. We show that it has theoretically plausible mechanisms, three flawed pre-clinical data, studies, and one incompletely documented case report supporting its use. We explain why further studies are needed to determine whether any specific light therapy protocol can help people with ALS.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esclerosis Amiotrófica Lateral Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Amyotroph Lateral Scler Frontotemporal Degener Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esclerosis Amiotrófica Lateral Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Amyotroph Lateral Scler Frontotemporal Degener Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido